Cormedix Inc Stock Ownership - Who owns Cormedix?

Insider buying vs selling

Have Cormedix Inc insiders been buying or selling?
Joseph TodiscoChief Executive Officer2024-01-1213,781$3.47
Matthew T. DavidChief Financial Officer2024-01-125,216$3.47
Erin MistryChief Commercial Officer2024-01-124,389$3.47
Elizabeth MassonhurlburtEVP Head of Clinical Ops.2024-01-124,603$3.47
Alan W. DuntonDirector2023-12-153,000$3.30
Alan W. DuntonDirector2023-12-143,000$3.45
Erin MistryChief Commercial Officer2023-11-171,000$4.00
Steven W. LefkowitzDirector2023-11-1615,000$2.25
Joseph TodiscoChief Executive Officer2023-09-0810,000$3.71
Myron KaplanDirector2023-05-186,000$4.54

1 of 3

CRMD insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRMD insiders and whales buy or sell their stock.

CRMD Shareholders

What type of owners hold Cormedix Inc stock?
Blackrock Inc6.40%3,507,695$11.51MInstitution
Nomura Holdings Inc5.38%2,946,552$9.66MInstitution
Vanguard Group Inc5.15%2,825,335$9.27MInstitution
Gary A. Gelbfish5.00%2,739,743$8.99MInsider
Elliott Investment Management LP2.83%1,550,523$5.09MInstitution
Geode Capital Management LLC2.11%1,158,808$3.80MInstitution
State Street Corp1.96%1,073,134$3.52MInstitution
Pharmabio Development Inc1.42%778,563$2.55MInsider
Randy Milby1.09%599,512$1.97MInsider
Marshall Wace LLP0.84%463,006$1.52MInstitution

1 of 3

CRMD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRMD34.11%10.99%Net BuyingNet Selling
LCTX34.36%65.64%Net BuyingNet Buying
INO60.49%39.51%Net Selling
FGEN71.24%12.65%Net SellingNet Selling
GNLX21.66%5.24%Net SellingNet Selling

Cormedix Stock Ownership FAQ

Who owns Cormedix?

Cormedix (NASDAQ: CRMD) is owned by 34.11% institutional shareholders, 10.99% Cormedix insiders, and 54.90% retail investors. Gary A. Gelbfish is the largest individual Cormedix shareholder, owning 2.74M shares representing 5.00% of the company. Gary A. Gelbfish's Cormedix shares are currently valued at $8.99M.

If you're new to stock investing, here's how to buy Cormedix stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.